Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-03-09

Clinical Trial Update: Comparison of Naloxone Pharmacokinetics [Phase 1]

View source ↗

Summary

Phase 1 study comparing naloxone pharmacokinetics in individuals with opioid use disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Naloxone (Naloxone)

Snippet

Sponsor: National Institute on Drug Abuse (NIDA) | Conditions: Opioid-use Disorder | Phase 1 | Status: COMPLETED